Multiple myeloma - Modern and Ayurvedic perspective- a critical review
DOI:
https://doi.org/10.55718/kja.155Keywords:
Multiple myeloma, Ayurveda, Myeloma biologyAbstract
Multiple myeloma (MM) represents a malignant proliferation of plasma cells derived from a single clone. It’s the most important of the class of diseases included under plasma cell dyscrasias. Multiple myeloma is the second most common haematological malignancy. Recent studies state that in India there is reporting of 2 cases for every 100,000 individuals which translates that there would be 50,000 new cases a year and that might be just the tip of the iceberg considering the large number of people. The etiopathogenesis and diagnosis of Multiple Myeloma have intrigued modern oncology researchers for decades, and it is still a rapidly growing area in medicine. MM is not a single disease, but rather a collection of related diseases which is diagnosed based on aberrant cellular changes. Since this is established by modern medical science, it becomes important to understand it from the perspective of Ayurveda. Even though there are a few endeavours in this area, in the past decades, unprecedented progress was made in research with a focus on understanding Myeloma biology, its pathogenesis, and the development of novel drugs. Even though lots of advancements have been made in the understanding of this disease, it has still not made its way into the category of curable diseases. This special issue reflects the understanding of multiple myeloma from an Ayurvedic point of view to be able to work towards turning Myeloma into a manageable one.
References
Kiss S, Gede N, Soós A, Hegyi P, Nagy B, Imrei M, Czibere B, Farkas N, Hanák L, Szakács Z, Eröss B, Alizadeh H. Efficacy of first-line treatment options in transplant-ineligible multiple myeloma: A network meta-analysis. Crit Rev Oncol Hematol. 2021 Dec;168:103504. *PubMed+
Koura DT, Langston AA. Inherited predisposition to multiple myeloma. Ther Adv Hematol. 2013 Aug;4(4):291-7. doi 10.1177/2040620713485375. PMID: 23926460; PMCID: PMC3734900.
Röllig C, Knop S, Bornhäuser M. Multiple myeloma. Lancet. 2015 May 30;385(9983):2197-208. *PubMed+
Weinhold N, Ashby C, Rasche L, Chavan SS, Stein C, Stephens OW, Tytarenko R, Bauer MA, Meissner T, Deshpande S, Patel PH, Buzder T, Molnar G, Peterson EA, van Rhee F, Zangari M, Thanendrarajan S, Schinke C, Tian E, Epstein J, Barlogie B, Davies FE, Heuck CJ, Walker BA, Morgan GJ. Clonal selection and double-hit events involving tumour suppressor genes underlie relapse in myeloma. Blood. 2016 Sep 29;128(13):1735-44. *PMC free article+ *PubMed+
Hameed A, Brady JJ, Dowling P, Clynes M, O'Gorman P. Bone disease in multiple myeloma: pathophysiology and management. Cancer Growth Metastasis. 2014;7:33-42. *PMC free article+ *PubMed+
Albagoush SA, Shumway C, Azevedo AM. Multiple Myeloma. *Updated 2023 Jan 30+. In: StatPearls *Internet+. Treasure Island (FL): StatPearls Publishing; 2023 Jan-.Available from: https://www.ncbi.nlm.nih.gov/books/NBK534764/
Kyle RA, Gertz MA, Witzig TE, Lust JA, Lacy MQ, Dispenzieri A, Fonseca R, Rajkumar SV, Offord JR, Larson DR, Plevak ME, Therneau TM, Greipp PR. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc. 2003 Jan;78(1):21-33. *PubMed+
Kyle RA, Rajkumar SV. Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma. Leukaemia. 2009; 23(1): 3–9.
Durie BG, Salmon SE. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer. 1975 Sep;36(3):842-54. doi: 10.1002/1097-0142(197509)36:3<842::aid-cncr2820360303>3.0.co;2-u. PMID: 1182674.
Becker, N. (2011). Epidemiology of Multiple Myeloma. In: Moehler, T., Goldschmidt, H. (eds) Multiple Myeloma. Recent Results in Cancer Research, vol 183. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-85772-3_2
Vaidya Trikamaji Yadavaji Acharya edited Charaka Samhita, Nidana Sthana, chapter no 4, sloka no. 4, edition 2013, page no. 212
Keriyavar AG, Shettar RV. Vikara Vighata Bhava - Concept of manifestation and the non-manifestation of a disease. journal of Ayurveda and integrated sciences. 2020Aug23;5(4):188–9.
Pandey K, Chaturvedi G. Vidyotini T, Achaarya Cand Dhrudhabala, Chaukhambha Bharati Academy, Varanasi, Edition 2003, Vol 1 1 Vimanasthana 5/17, 713p
Acharya, Dalhana. Sushruta Samhita. shareera sthana, chapter 04, sloka no.16-17, e samhita sushrutha samhita, https://niimh.nic.in/ebooks/esushruta/?mod=read, Accessed 2023.
“Exposure to Pollution Causes 10% of All Cancer Cases in Europe.” European Environment Agency, 7 Feb. 2023, https://www.eea.europa.eu/highlights/pollution-and-cancer.
Dhiman K, Kumar A, Dhiman KS. Shad Garbhakara Bhavas vis-a-vis congenital and genetic disorders. Ayu. 2010 Apr;31(2):175-84. doi 10.4103/0974-8520.72384. PMID: 22131707; PMCID: PMC3215361.
Schneider KA. 2nd ed. Dennisport, Massachusetts: Graphic Illusions; 1994. Counselling about Cancer: Strategies for Genetic Counselors. *Google Scholar+
Sharma H, Keith Wallace R. Ayurveda, and Epigenetics. Medicina (Kaunas). 2020 Dec 11;56(12):687. doi: 10.3390/medicina56120687. PMID: 33322263; PMCID: PMC7763202.
Mohan H. textbook of pathology. 7th ed. Daryaganj, New Delhi: Jaypee brothers medical publishers; 2015.chapter no.7, pg no-201-202
Basumatary, Dr Khagen, and Dr Chumi Bhatta. “AGNI IN NYAYA-VAISESIKA DARSHAN.” Indian Journal of Applied Research, vol. 9, no. 7, July 2019, pp. 26–27.
Ullah, Tomalika. (2019). The Role of CXCR4 in Multiple Myeloma: Cells’ Journey from Bone Marrow to Beyond. Journal of Bone Oncology. 17. 100253. 10.1016/j.jbo.2019.100253.
Nazhat Parveen et al: Arbuda- Concept of Cancer Etiopathogenesis as In Ayurveda- A Review. International Ayurvedic Medical Journal ,online- 2022 ,cited August 2022- Availablefrom: http://www.iamj.in/posts/images/upload/2136_2141.pdf
Bhosgikar A. A review on Shatkriyakala. Int Ayurved Med J. 2014; 2: 318–324
Gupta KA. Astanga Hridayam, Hindi Commentary. Varanasi: Choukhamba Prakashan. 2007: 91. Hindi
Jadavaji TA. Sushruta Samhita of Sushruta with Nibandhasamgraha Commentary. 9th ed. Varanasi: Choukhamba Orientalia. 2007: 104. Hindi.
Ghanekar BG. Sushruta Samhita Sutrasthan. New Delhi: Meharchand Lacchmandas Publications. 1998: 137. Hindi.
Shirke PR, Deshmukh PN, Patil RB, Kirte MC, Sawant DP. Study of Dhatupradoshaja Vikar w.s.r.t. Raktadhatupradoshaja Vikara: a literary review. Int J Ayu Alt Med. 2016; 4: 116–122
Kumar B, Paliwal M. Concept of Shatkriyakala as mentioned in Sushruta Samhita. J Adv Res Ayur Yoga Unani Sidd Homeo. 2014; 1: 10–12.
Healthepic.com. Kriyakala. (2001) *2016-06-17+. http:// www.healthepic.com/ayurveda/diagnosis/kriyakala.html.
Onyemaechi Okolo, Betsy C. Wertheim, Ashley Larsen, Nathan W. Sweeney, Jennifer M. Ahlstrom, Krisstina Gowin, Integrative medicine in multiple myeloma and plasma cell disorders, Complementary Therapies in Medicine, Volume 73,2023,102939, ISSN0965 2299, https://doi.org/10.1016/j.ctim.2023.102939 (https://www.sciencedirect.com/science/article/pii/S0965229923000262)
